Does a central review platform improve the quality of radiotherapy for rectal cancer? Results of a national quality assurance project

Radiotherapy and Oncology

Volumn 111, Issue 3, 2014, Pages 400-405

  Joye, Ines ^a,b   Lambrecht, Maarten ^a,b   Jegou, David ^c   Hortobágyi, Eszter ^a,b   Scalliet, Pierre ^d   Haustermans, Karin ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Belgian Cancer Registry ^*  (Belgium)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Central review; Quality assurance; Radiotherapy; Rectal cancer; Target delineation

Indexed keywords

AGED; ARTICLE; BELGIUM; CANCER RADIOTHERAPY; CENTRAL REVIEW PLATFORM; CLIENT SERVER APPLICATION; CLINICAL PRACTICE; CLINICAL TARGET VOLUME; COMMONLY CONTOURED VOLUME; CONSENSUS; DICE COEFFICIENT; E-MAIL; FEEDBACK SYSTEM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY CONTROL; RADIOLOGICAL PARAMETERS; RECTUM CANCER; VOLUMETRIC RATIO; ADULT; BELGIAN; BREAST CANCER; INDEPENDENT VARIABLE; INGUINAL LYMPH NODE; IRRADIATION; RESPONSE VARIABLE; TUMOR CLASSIFICATION; UNIVERSITY HOSPITAL;

CENTRAL REVIEW; QUALITY ASSURANCE; RADIOTHERAPY; RECTAL CANCER; TARGET DELINEATION;

ADULT; AGED; AGED, 80 AND OVER; BELGIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; RADIATION ONCOLOGY; RADIOTHERAPY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RECTAL NEOPLASMS; YOUNG ADULT;

EID: 84905251316     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.03.003     Document Type: Article

References (23)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. K.Y. Bilimoria, J.D. Phillips, and C.E. Rock et al. Effect of surgeon training, specialization, and experience on outcomes for cancer surgery: a systematic review of the literature Ann Surg Oncol 16 2009 1799 1808
3. W. Hohenberger, S. Merkel, and P. Hermanek Volume and outcome in rectal cancer surgery: the importance of quality management Int J Colorectal Dis 28 2013 197 206
4. S.L. Bosch, and I.D. Nagtegaal The importance of the pathologist's role in assessment of the quality of the mesorectum Curr Colorectal Cancer Rep 8 2012 90 98
5. P. Quirke, R. Steele, and J. Monson et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial Lancet 373 2009 821 828
6. L.J. Peters, B. O'Sullivan, and J. Giralt et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02 J Clin Oncol 28 2010 2996 3001
7. R.A. Abrams, K.A. Winter, and W.F. Regine et al. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704 - a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas Int J Radiat Oncol Biol Phys 82 2012 809 816
8. E. Jullumstro, A. Wibe, S. Lydersen, and T.H. Edna Violation of treatment guidelines - hazard for rectal cancer patients Int J Colorectal Dis 27 2012 103 109
9. N. Ohri, X. Shen, A.P. Dicker, L.A. Doyle, A.S. Harrison, and T.N. Showalter Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials J Natl Cancer Inst 105 2013 387 393
10. Belgian Healthcare Knowledge Centre guidelines on rectal cancer. https://kce.fgov.be/sites/default/files/page-documents/d20071027354.pdf.
11. S. Roels, W. Duthoy, and K. Haustermans et al. Definition and delineation of the clinical target volume for rectal cancer Int J Radiat Oncol Biol Phys 65 2006 1129 1142
12. D.C. Weber, M. Tomsej, C. Melidis, and C. Hurkmans QA makes a clinical trial stronger: evidence-based medicine in radiation therapy Radiother Oncol 105 2012 4 8
13. K.A. Goodman Quality assurance for radiotherapy: a priority for clinical trials J Natl Cancer Inst 105 2013 376 377
14. J.A. Purdy Quality assurance issues in conducting multi-institutional advanced technology clinical trials Int J Radiat Oncol Biol Phys 71 2008 S66 S70
15. A. Fairchild, E. Aird, and P.A. Fenton et al. EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility Radiother Oncol 103 2012 279 286
16. J.R. Palta, V.A. Frouhar, and J.F. Dempsey Web-based submission, archive, and review of radiotherapy data for clinical quality assurance: a new paradigm Int J Radiat Oncol Biol Phys 57 2003 1427 1436 (Pubitemid 37443985)
17. P. Van Houtte, N. Bourgois, F. Renard, P. Huget, W. D'hoore, and P. Scalliet A federal audit of the Belgian radiotherapy departments in breast cancer treatment Radiother Oncol 83 2007 178 186 (Pubitemid 46783924)
18. C.D. Fuller, J. Nijkamp, and J.C. Duppen et al. Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting Int J Radiat Oncol Biol Phys 79 2011 481 489
19. J. Nijkamp, D.F. de Haas-Kock, and J.C. Beukema et al. Target volume delineation variation in radiotherapy for early stage rectal cancer in the Netherlands Radiother Oncol 102 2012 14 21
20. P. Fenton, C. Hurkmans, and A. Gulyban et al. Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure Radiother Oncol 107 2013 346 351
21. A. Fairchild, D.C. Weber, and R. Bar-Deroma et al. Quality assurance in the EORTC 22033-26033/CE5 phase III randomized trial for low grade glioma: the digital individual case review Radiother Oncol 103 2012 287 292
22. O. Matzinger, P. Poortmans, and J.Y. Giraud et al. Quality assurance in the 22991 EORTC ROG trial in localized prostate cancer: dummy run and individual case review Radiother Oncol 90 2009 285 290
23. I. Fotina, C. Lutgendorf-Caucig, M. Stock, R. Potter, and D. Georg Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy Strahlenther Onkol 188 2012 160 167